Digital Pathology Industry Worth $2.0 billion by 2029, with a CAGR of 13.1%
The report "Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2029", is projected to reach USD 2.0 billion by 2029 from USD 1.1 billion in 2024, at a CAGR of 13.1%.
Browse 248 market data Tables and 48 Figures spread through 264 Pages and in-depth TOC on "Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/digital-pathology-market-844.html
The growth in the digital pathology market is driven by the technological advancements, increasing adoption of telepathology, rising prevalence of chronic diseases, cost-effectiveness, increasing educational and research applications. However, data security and privacy concerns pose a challenge to the market growth.
Scanners segment accounted for the largest share of the global Digital Pathology market in 2023.
On the basis type, the Digital Pathology market is segmented into scanners, software, and storage systems segment. The scanners segment accounted for the largest share of the product segment in 2023. The high demand for scanners is driven by continuous technological advancements, including higher resolution imaging, faster scanning speeds, and improved automation capabilities. These enhancements significantly reduce the time and labor required in pathology workflows, making scanners a critical component of modern pathology laboratories.
By type, human pathology segment registers the highest growth rate during the forecast period.
Based on type, the Digital Pathology market is segmented into human pathology and veterinary pathology. Human pathology to register the high growth rate during forecast period due to the increasing demand for accurate, efficient, and timely diagnostic services. With the rising prevalence of chronic diseases such as cancer, there is a growing need for precise pathological assessments to guide treatment decisions. Digital pathology offers significant advantages over traditional methods, including enhanced image analysis, better storage and retrieval of pathology slides, and the ability to share images easily for second opinions and collaborative diagnostics.
The Drug Discovery segment accounted for the largest share of the global Digital Pathology market in 2023.
Based on application, the Digital Pathology market is segmented into drug discovery, disease diagnosis, training and education segment. The drug discovery segment accounted for the largest share of the application segment in 2023 due to its ability to significantly enhance the efficiency and accuracy of the drug development process. Digital pathology enables high-throughput screening of tissue samples, allowing researchers to analyze vast datasets quickly and accurately. This accelerates the identification of potential drug candidates and their effects at a cellular level.
Pharmaceutical and biotechnology companies are largest end users of the Digital Pathology market.
Based on end users, the Digital Pathology market is segmented into pharmaceutical and biotechnology companies, hospital and reference laboratories, and academic and research institutes. The pharmaceutical and biotechnology companies held the largest share among the end-users in 2023 due to due to several compelling factors. These companies rely extensively on digital pathology for drug discovery, development, and personalized medicine. The advanced imaging and analysis capabilities of digital pathology facilitate precise and efficient examination of tissue samples, significantly accelerating the drug development process. High-throughput screening and automated image analysis enable rapid processing and analysis of vast data sets, which is critical for identifying potential drug candidates and understanding their effects on biological tissues.
North America dominates the global Digital Pathology market.
The Digital Pathology market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2023, North America accounted for the largest share of the Digital Pathology market. This region’s dominance is due to several interrelated factors that create a conducive environment for its growth. Firstly, the region boasts advanced healthcare infrastructure and significant investment in healthcare technologies, allowing for the adoption of cutting-edge digital pathology systems. Additionally, North America, particularly the US, has a high prevalence of chronic diseases and cancer, driving the demand for efficient and accurate diagnostic tools. The presence of key market players and leading research institutions in the region fosters innovation and the development of new digital pathology solutions.
Key Players
Prominent players in the digital pathology market include Huron Digital Pathology (Canada), Hologic, Inc. (US), Corista (US), Indica Labs Inc. (US), 3DHISTECH (Hungary), Objective Pathology Services Limited (Canada), OptraSCAN (US), Sectra AB (Sweden), Akoya Biosciences, Inc. (US), Hamamatsu Photonics K.K. (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), Apollo Enterprise Imaging (US), XIFIN, Inc. (US), Proscia Inc. (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China), Glencoe Software, Inc. (US), Aiforia (Finland), Paige AI, Inc. (US), Fujifilm Holdings Corporation (Japan), Danaher Corporation (US), Koninklijke Philips N.V. (Netherlands), Mikroscan Technologies, Inc. (US), PathAI (US), Motic Digital Pathology (US), and Kanteron Systems (Spain).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Digital Pathology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
